SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event
reported) September 25, 2012
FUSE SCIENCE, INC.
(Exact Name of Registrant as Specified
(State or Other Jurisdiction
|6135 NW 167th Street, #E-21
Miami Lakes, Florida
|(Address of Principal Executive Offices)
(Registrant’s telephone number,
Including Area Code)
Check the appropriate
box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
|£||Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|£||Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|£||Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|£||Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|Item 4.01||Changes in Registrant’s Certifying Accountant
of Paritz & Company, P.A.
September 25, 2012, Fuse Science, Inc. (the “Company”) terminated Paritz & Company, P.A. (“Paritz”)
as its principal independent registered public accounting firm. The decision to terminate Paritz was recommended by the audit committee
of the Company’s board of directors and approved by the board of directors as a whole.
report of Paritz on the Company’s financial statements for the fiscal years ended September 30, 2011 and 2010, did not contain
an adverse opinion or disclaimer of opinion, nor was it modified as to uncertainty, audit scope or accounting principles, except
that Paritz’s report for those fiscal years includes an explanatory paragraph and note stating, among other things, that
the Company has incurred a loss since inception, has a net accumulated deficit and may be unable to raise further equity, which
raises substantial doubt about the Company’s ability to continue as a going concern.
the fiscal years ended September 30, 2011 and 2010 and during the subsequent period through to the date of Paritz’s termination,
there were no disagreements between the Company and Paritz, whether or not resolved, on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to the satisfaction of Paritz,
would have caused Paritz to make reference thereto in its report on the Company’s audited financial statements. In connection
with the audits of the fiscal years ended September 30, 2011 and 2010 and the subsequent interim period through September 25, 2012,
there have been no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K).
Company provided Paritz with a copy of this Current Report on Form 8-K and has requested that Paritz furnish the Company with
a letter addressed to the Securities and Exchange Commission stating whether or not Paritz agrees with the statements made in this
Current Report on Form 8-K with respect to Paritz and, if not, stating the aspects with which they do not agree. The
Company has received the requested letter from Paritz wherein they have confirmed their agreement to the Company’s disclosures
in this Current Report with respect to Paritz. A copy of Paritz's letter has been filed as an exhibit to this Current
Report on Form 8-K.
of Morrison Brown Argiz and Farra, LLC
September 25, 2012, the Company engaged Morrison Brown Argiz and Farra, LLC (“MBAF”) as the Company’s
independent registered public accounting firm. The engagement was recommended by the audit committee of the Company’s board
of directors and approved by the Company’s board of directors as a whole.
connection with the Company’s appointment of MBAF as the Company’s independent registered accounting firm, the Company
has not consulted MBAF on any matter relating to the application of accounting principles to a specific transaction, either completed
or contemplated, or the type of audit opinion that might be rendered on the Company’s financial statements.
|Item 9.01||Financial Statements and Exhibits
||Letter from Paritz & Company, P.A., as to change in certifying accountant.|
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
||FUSE SCIENCE, INC.|
|| /s/ Brian Tuffin|
||Brian Tuffin, Chief Executive Officer and Acting Chief Financial Officer |
Dated: September 27, 2012